Login / Signup

Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel Regimen for Borderline Resectable Pancreatic Cancer with Arterial Involvement: A Prospective Multicenter Single-Arm Phase II Study Protocol.

Yoshihiro MiyasakaTakao OhtsukaSusumu EguchiMasafumi InomataKazuyoshi NishiharaHiroyuki ShinchiKoji OkudaHideo BabaHiroaki NaganoToshiharu UekiHirokazu NoshiroMasafumi Nakamuranull null
Published in: International journal of surgery protocols (2021)
Strategy for borderline resectable pancreatic cancer involving arteries (BRPC-A).There is no standard regimen for neoadjuvant chemotherapy for BRPC-A.Gemcitabine plus nab-paclitaxel (GnP) shows significant tumor shrinkage.Neoadjuvant GnP for BRPC-A increases resectability and margin-negative resection.
Keyphrases